FOXO3 and ischemic stroke: In our study, we demonstrated that intracerebral implantation of FOXO3-engineered human mesenchymal stem cells (F3-MSCs) advances functional recovery in mice after ischemic stroke induced by middle-cerebral-artery-occlusion (MCAO).